Business
Add as a preferred source on GoogleThe SEC index lists Items 2.02 and 9.01 and records Nov. 2 as both the filing date and report date.
The SEC index shows BIOMARIN PHARMACEUTICAL INC filed a Form 8-K on Nov. 2, with the report also dated Nov. 2. The filing lists Item 2.02, “Results of Operations and Financial Condition,” and Item 9.01, “Financial Statements and Exhibits.”
The 14-document submission carries accession number 0001048477-26-000021. Its index lists an EX-99.1 document named earningsrelease-2nov26ex991.htm, along with the 8-K, a graphic and XBRL files.
The SEC index identifies Oct. 22 as both the filing date and period of report and lists two disclosure items.
The SEC index lists items covering results and financial condition, and financial statements and exhibits.
The SEC index counts 13 documents and lists items on acquisition completion, listing status, security-holder rights, control, corporate governance and financial exhibits.
